Bioequivalence of a biosimilar enoxaparin sodium to Clexane® after single 100 mg subcutaneous dose: results of a randomized, double-blind, crossover study in healthy volunteers.
| Autor: | González, Javier Martínez, Monreal, Mayte, Almagia, Ignacio Ayani, Garín, Jordi Llaudó, Monasterioguren, Lourdes Ochoa Díaz de, Adúriz, Ibón Gutierro |
|---|---|
| Zdroj: | Drug Design, Development & Therapy; 2018, Vol. 12, p575-582, 8p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|